State-owned China Traditional Chinese Medicine is buying an 81.5 percent stake in a competitor.
January 29, 2015 at 01:11 AM
1 minute read
The original version of this story was published on Global Lawyer News
Kirkland & Ellis is representing state-owned China Traditional Chinese Medicine Co. Ltd. on a $1.34 billion investment in Jiangyin Tianjiang Pharmaceutical Co. Ltd.
Traditional Chinese Medicine plans to acquire an 81.5 percent stake in Jiangyin Tianjiang, a manufacturer of concentrated traditional Chinese medicine granules based in eastern China’s Jiangsu province.
Presented by BigVoodoo
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
